Introducing eXalt - a new, non-destructive evaporation technology from Genevac, was developed with partners in the field of pharmaceutical small molecule crystallization. This technology is suitable for labs that perform tasks including first time crystallization of amorphous 
forms, recrystallization of samples which have only a few known forms, removing a hydrate, solvent screening studies to find the most suitable conditions to take forward in development, high throughput co-crystallization screens and studies to confirm stable isoforms. eXalt enables a wide range of solvents and multiple actives to be evaporated all at the same slow rate and under the same conditions, giving the user control of the crystallization process. The system can accept up to 24 different samples, and 4 8 or 12 holders can be placed in the evaporator, depending on size.
Genevac Ltd.
